Post dural puncture headache (PDPH)

As an anesthesiologist, it’s essential to delve into the intricacies of post dural puncture headache (PDPH), also referred to as post lumbar puncture headache. This common complication arises following diagnostic lumbar punctures, spinal anesthesia, and unintended dural punctures during epidural catheter placements. PDPH is characterized by its distinctive positional nature – intensifying in an upright position and easing when reclined. Patients may also experience associated symptoms such as neck stiffness, sensitivity to light, nausea, and auditory disturbances. A comprehensive understanding of the historical context, pathophysiology, incidence, and risk factors associated with PDPH empowers anesthesiologists to provide effective management and pre-emptive strategies.

Historical Context: The recognition of PDPH dates back to the early days of lumbar punctures, which have been performed for over a century. The initial descriptions of this headache emerged in the early 20th century when diagnostic lumbar punctures became a valuable diagnostic tool. As the field of anesthesia evolved, the use of spinal anesthesia and epidural catheters introduced new avenues for encountering PDPH. The historical journey highlights the persistent challenge of managing and preventing this intricate phenomenon, fostering the need for a nuanced understanding of its mechanisms.

Pathophysiology: The pathophysiology of PDPH delves into the dynamic interplay between cerebrospinal fluid (CSF) dynamics, intracranial structures, and vascular responses. While not fully elucidated, several theories provide insights into the underlying mechanisms:
  1. CSF Hypotension and Venodilation: The hallmark theory suggests that CSF leakage through the dural hole created by the needle leads to reduced CSF pressure. In upright positions, this phenomenon is accentuated within the cranial compartment. Compensatory mechanisms kick in, resulting in meningeal venodilation and blood volume expansion. These changes manifest as acute venous distention, substantiated by MRI findings that demonstrate venous engorgement during PDPH.
  2. Intracranial Hypotension and Nerve Stretch: CSF leakage-induced intracranial hypotension triggers sagging of intracranial structures and stretch of sensory intracranial nerves. This dynamic brings about pain and potential cranial nerve disturbances. MRI studies showing downward brain displacement in intracranial hypotension cases, which reverses as headache symptoms alleviate, underscore the role of upper cervical nerve traction in contributing to the accompanying neck, back, and shoulder pain associated with PDPH.
  3. Altered Craniospinal Elasticity: Lumbar punctures perturb the compliance balance between the cranial and spinal compartments. This imbalance leads to increased compliance in the caudal direction relative to the intracranial region. As a result, assuming an upright position induces acute intracranial venodilation. This concept aptly explains the positional facet of PDPH.
Incidence: A grasp of PDPH’s incidence aids anesthesiologists in assessing risks and counseling patients. Incidence rates for PDPH post spinal anesthesia generally remain below 3%, although they can rise to around 9% contingent upon needle characteristics. Diagnostic lumbar punctures with traumatic needles yield an incidence of approximately 11%. Obstetric patients, who are particularly vulnerable, experience an incidence ranging between 81% and 88% following unintentional dural puncture during epidural placements.

Risk Factors: Understanding risk factors associated with PDPH is crucial for tailoring patient care and preemptive strategies:
  • Patient-Related Risk Factors: The female demographic displays heightened susceptibility to PDPH, exacerbated during pregnancy due to hormonal and anatomical changes. The age range of 18 to 50 years and a history of prior headaches, including PDPH, amplify vulnerability. Low opening pressure during lumbar puncture, substantial CSF volume removal, and potentially low BMI contribute to increased risk.
  • Procedural-Related Risk Factors: Needle selection plays a pivotal role. Pencil point needles are favored over cutting needles due to their lower PDPH risk. Larger needle size and transverse insertion of cutting needles elevate the likelihood of PDPH. The impact of reinserting the stylet before needle removal remains inconclusive. Additional procedural factors, including the combined spinal-epidural technique and needle placement position, influence PDPH risk.
Prevention and Management of Post-Dural Puncture Headache (PDPH) in Anesthesia: A Comprehensive Guide for Anesthesiologists
Introduction: Anesthesiologists often encounter the challenge of post-dural puncture headache (PDPH) following procedures involving dural puncture. This complication can significantly impact patient recovery and well-being. Understanding comprehensive prevention and management strategies, including specific dose details, is paramount for optimizing patient outcomes.

  1. Bedrest: Despite historical recommendations, extended bedrest post-dural puncture doesn’t significantly reduce PDPH risk. Immediate mobilization or shorter bed rest is equally effective. While bed rest doesn’t prevent PDPH, it can alleviate the intensity of the headache.
  2. Abdominal Binder: The utilization of abdominal binders post unintentional dural puncture (UDP) during epidural anesthesia is a theoretical approach. Abdominal compression with a tight binder may transmit increased intra-abdominal pressure to the epidural space, potentially sealing the puncture site, reducing cerebrospinal fluid (CSF) leakage, and alleviating existing headache. However, evidence for its efficacy is limited.
  3. Prophylactic Drug Therapy:
    • Epidural Morphine: Limited evidence suggests that epidural morphine administration can potentially reduce PDPH incidence. A study used 3-5 mg of epidural morphine prophylactically.
    • IV Cosyntropin: Intravenous cosyntropin has shown promise in decreasing PDPH incidence. Intravenous administration of 0.25 mg cosyntropin has been studied.
    • Ondansetron: Ondansetron may reduce the risk of PDPH. A dose of 0.15 mg/kg IV or a fixed dose of ondansetron (e.g., 4 mg) administered during spinal anesthesia has been studied.
  4. Prophylactic Epidural Blood Patch (EBP): EBP is an effective treatment for PDPH and may also be performed prophylactically post UDP during epidural catheter placement. Evidence regarding prophylactic EBP’s efficacy is variable, but it may reduce the intensity and duration of symptoms.
  5. Intrathecal Catheter Placement: Inserting an intrathecal catheter after UDP aims to reduce PDPH incidence. While evidence is inconclusive, selective use of intrathecal catheters post UDP, especially after challenging epidural procedures, might be considered.
  1. Mild PDPH: Patients tolerating upright positions and daily activities have mild PDPH. Conservative treatment, including oral analgesics and antiemetics, may be effective. Vigorous oral and/or IV hydration are recommended.
  2. Debilitating PDPH: Patients unable to tolerate sitting/standing due to severe headache require more aggressive management. An epidural blood patch (EBP) is the definitive treatment for PDPH.
Epidural Blood Patch (EBP):
  • Technique: Injecting the patient’s autologous blood through an epidural needle into the epidural space.
  • Mechanism: Blood injection compresses the thecal sac, increasing lumbar and intracranial CSF pressure, potentially sealing the puncture site.
  • Dosing: Approximately 20 mL of autologous blood is recommended for EBP. Injection should be stopped if the patient experiences significant pain or pressure.
  • Success Rate: Initial success rate after EBP ranges from 65% to 98%. A second EBP has a similar success rate if required.
  • Contraindications: EBP is contraindicated in coagulopathy, anticoagulation, systemic infection, and infection at needle placement site.
  • Complications: Back pain is common (25-35%). Rare complications include subdural hematoma, intrathecal injection, and infection.
Drug Therapy:
  • Caffeine: Patients accustomed to caffeine intake can be encouraged to self-administer oral caffeine to prevent caffeine withdrawal symptoms. No specific dose is provided due to patient-specific variations.
  • Analgesics: Simple or combination analgesics (e.g., butalbital-acetaminophen-caffeine) can provide symptomatic relief. Dosing should be tailored based on the specific analgesic components.
  • Other Drugs: Gabapentin, hydrocortisone, theophylline, and neostigmine/atropine have shown some efficacy in decreasing PDPH severity, but optimal dosing remains uncertain.
Alternative Treatments:
  • Transnasal Sphenopalatine Block (SPGB): Limited evidence supports the use of topical intranasal local anesthetic for SPGB. Dosing details for local anesthetics (e.g., 2-5% lidocaine) are not standardized due to variations in clinical practice.
  • Greater Occipital Nerve Block: Interrupts pain transmission by blocking trigeminal and greater occipital nerves activated by dural stretch. Dosing for local anesthetics used in the block varies and should be individualized.

Leave a Comment